Search company, investor...

Meditrina Pharmaceuticals

meditrina.com

Founded Year

2006

Stage

Debt | Alive

Total Raised

$4.45M

Last Raised

$50K | 12 yrs ago

About Meditrina Pharmaceuticals

Meditrina Pharmaceuticals, Inc. is a clinical-stage, specialty pharmaceutical company focused on developing and commercializing therapies that treat women's reproductive system disorders, with an initial focus on gynecologic and aromatase-mediated conditions with serious unmet medical needs.

Headquarters Location

Ann Arbor, Michigan, 48104,

United States

734-926-0966

Missing: Meditrina Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Meditrina Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Meditrina Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Meditrina Pharmaceuticals is included in 2 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

1,482 items

Startups focused on providing products and services catering to women's health and wellbeing.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Meditrina Pharmaceuticals Patents

Meditrina Pharmaceuticals has filed 1 patent.

The 3 most popular patent topics include:

  • Endoscopy
  • Medical equipment
  • Surgical procedures and techniques
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/11/2018

9/6/2022

Endoscopy, Medical equipment, Sensors, Environmental engineering, Sewerage

Grant

Application Date

10/11/2018

Grant Date

9/6/2022

Title

Related Topics

Endoscopy, Medical equipment, Sensors, Environmental engineering, Sewerage

Status

Grant

Latest Meditrina Pharmaceuticals News

Acquisition: Romanian startup Solartium becomes Meditrina

Apr 4, 2022

The Romanian startup Solartium becomes Meditrina after an acquisition by the pharmaceutical company Meditrina Pharmaceuticals, which is one of the fastest-growing pharmaceutical companies in South-Eastern Europe. The acquisition is a good opportunity for the Romanian pharmaceutical market to expand and grow, bringing better conditions for patients and doctors. On the other hand, Maditrina Pharmaceuticals will strengthen […] Der Beitrag Acquisition: Romanian startup Solartium becomes Meditrina erschien zuerst auf Trending Topics.

Meditrina Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Meditrina Pharmaceuticals founded?

    Meditrina Pharmaceuticals was founded in 2006.

  • Where is Meditrina Pharmaceuticals's headquarters?

    Meditrina Pharmaceuticals's headquarters is located at Ann Arbor.

  • What is Meditrina Pharmaceuticals's latest funding round?

    Meditrina Pharmaceuticals's latest funding round is Debt.

  • How much did Meditrina Pharmaceuticals raise?

    Meditrina Pharmaceuticals raised a total of $4.45M.

  • Who are the investors of Meditrina Pharmaceuticals?

    Investors of Meditrina Pharmaceuticals include 21st Century Jobs Fund and Biosciences Research and Commercialization Center.

  • Who are Meditrina Pharmaceuticals's competitors?

    Competitors of Meditrina Pharmaceuticals include Adastra Pharmaceuticals, Aegerion Pharmaceuticals, Meritage Pharma, Questcor Pharmaceuticals, Auris Medical and 15 more.

Compare Meditrina Pharmaceuticals to Competitors

I
IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.

P
P2D Biosciences

P2D, Inc. is a pharmaceutical company focused on developing new pharmaceuticals for brain disorders

X
Xenome

Xenome focuses on the discovery and development of peptide pharmaceuticals based on libraries of venom and related peptides.

Neurelis Logo
Neurelis

Neurelis is a specialty pharmaceutical company that devleops and commercializes product candidates for epilepsy and the broader central nervous system (CNS) market.

O
Osteologix

Osteologix develops pharmaceutical products for bone and cartilage disorders addressing large markets and offering low-risk development. The therapies developed by Osteologix represent valuable solutions to the patients suffering from diseases of bone and cartilage, and they represent cost-effective therapeutic options for the healthcare providers. Osteologix's lead compound for prophylaxis and treatment of osteoporosis is being developed for multiple clinical indications. The main program is aimed at osteoporosis. Additional programs are aimed at secondary indications in metabolic bone diseases and OA exploiting maximal synergies with the Osteoporosis program.

P
Predictek

An R&D company focusing on technologies in imaging. Predictek analyzes functional brain images for the pharmaceutical industry, and is developing a new kind of multispectral imaging for use by eye care professionals.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.